A | ||||
---|---|---|---|---|
Treatment | CAV1 | ENO2 | PKCα | DHFR |
siCAV1 + siENO2 + siPKCα | 50.1 ± 4.3 | 50.5 ± 4.4 | 66.2 ± 2.6 | 82.9 ± 2.3 |
siCAV1 + siENO2 + siPKCα + siDHFR | 37.7 ± 3.7 | 59.1 ± 0.8 | 47.6 ± 4.7 | 47.3 ± 1.2 |
400 nM NR-siRNA | 96.8 ± 10.4 | 98.4 ± 0.5 | 96.3 ± 0.3 | 100.6 ± 13.4 |
B | ||||
Treatment | CAV1 | ENO2 | PKCα | DHFR |
siCAV1 + siENO2 + siPKCα | 62.7 ± 0.2 | 44.20 ± 0.9 | 73.2 ± 4.9 | 97.7 ± 8.8 |
siCAV1 + siENO2 + siPKCα + siDHFR | 45.4 ± 0.8 | 36.34 ± 4.2 | 40.6 ± 2.5 | 33.4 ± 3.8 |
400 nM NR-siRNA | 99.1 ± 9.2 | 100.57 ± 15.9 | 103.2 ± 1.1 | 95.5 ± 10.2 |